These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24146040)

  • 1. Heparan sulfate in angiogenesis: a target for therapy.
    van Wijk XM; van Kuppevelt TH
    Angiogenesis; 2014 Jul; 17(3):443-62. PubMed ID: 24146040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 4-deoxy analogue of N-acetyl-D-glucosamine inhibits heparan sulphate expression and growth factor binding in vitro.
    van Wijk XM; Oosterhof A; van den Broek SA; Griffioen AW; ten Dam GB; Rutjes FP; van Delft FL; van Kuppevelt TH
    Exp Cell Res; 2010 Sep; 316(15):2504-12. PubMed ID: 20433828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interfering with UDP-GlcNAc metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesis.
    van Wijk XM; Thijssen VL; Lawrence R; van den Broek SA; Dona M; Naidu N; Oosterhof A; van de Westerlo EM; Kusters LJ; Khaled Y; Jokela TA; Nowak-Sliwinska P; Kremer H; Stringer SE; Griffioen AW; van Wijk E; van Delft FL; van Kuppevelt TH
    ACS Chem Biol; 2013 Oct; 8(10):2331-8. PubMed ID: 23972127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
    Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
    Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial heparan sulfate in angiogenesis.
    Fuster MM; Wang L
    Prog Mol Biol Transl Sci; 2010; 93():179-212. PubMed ID: 20807646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis.
    Ferro V; Dredge K; Liu L; Hammond E; Bytheway I; Li C; Johnstone K; Karoli T; Davis K; Copeman E; Gautam A
    Semin Thromb Hemost; 2007 Jul; 33(5):557-68. PubMed ID: 17629854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between heparan sulfate and proteins: the concept of specificity.
    Kreuger J; Spillmann D; Li JP; Lindahl U
    J Cell Biol; 2006 Jul; 174(3):323-7. PubMed ID: 16880267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiprotein signalling complexes: regional assembly on heparan sulphate.
    Gallagher JT
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):438-41. PubMed ID: 16709181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase activation induces epidermal hyperplasia, angiogenesis, lymphangiogenesis and wrinkles.
    Iriyama S; Matsunaga Y; Amano S
    Exp Dermatol; 2010 Nov; 19(11):965-72. PubMed ID: 20100191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth.
    Johnstone KD; Karoli T; Liu L; Dredge K; Copeman E; Li CP; Davis K; Hammond E; Bytheway I; Kostewicz E; Chiu FC; Shackleford DM; Charman SA; Charman WN; Harenberg J; Gonda TJ; Ferro V
    J Med Chem; 2010 Feb; 53(4):1686-99. PubMed ID: 20128596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates.
    Blackhall FH; Merry CL; Lyon M; Jayson GC; Folkman J; Javaherian K; Gallagher JT
    Biochem J; 2003 Oct; 375(Pt 1):131-9. PubMed ID: 12812520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic factors in chronic lymphocytic leukemia.
    Xia Y; Lu RN; Li J
    Leuk Res; 2012 Oct; 36(10):1211-7. PubMed ID: 22727510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
    J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate regulation of progenitor cell fate.
    Cool SM; Nurcombe V
    J Cell Biochem; 2006 Nov; 99(4):1040-51. PubMed ID: 16767693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants.
    Gaetzner S; Deckers MM; Stahl S; Löwik C; Olsen BR; Felbor U
    Matrix Biol; 2005 Jan; 23(8):557-61. PubMed ID: 15694132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses.
    Ferro V
    Expert Opin Ther Targets; 2013 Aug; 17(8):965-75. PubMed ID: 23789629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic heparan sulfate ligands for vascular endothelial growth factor to modulate angiogenesis.
    Jain P; Shanthamurthy CD; Leviatan Ben-Arye S; Yehuda S; Nandikol SS; Thulasiram HV; Padler-Karavani V; Kikkeri R
    Chem Commun (Camb); 2021 Apr; 57(28):3516-3519. PubMed ID: 33704312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate-protein interactions--a concept for drug design?
    Lindahl U
    Thromb Haemost; 2007 Jul; 98(1):109-15. PubMed ID: 17598000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.